Taysha Gene Therapies Inc (NASDAQ: TSHA): Do Not Miss The Gain Train
Taysha Gene Therapies Inc (TSHA) concluded trading on Thursday at a closing price of $2.46, with 3.05 million shares of worth about $7.51 million changed hands on the day. Half year performance of the stock remained positive as price took a surge of 28.12% during that period and on July 11, 2024 the price saw […]
Taysha Gene Therapies Inc (NASDAQ: TSHA) – Suitable For Long Term Buy?
Currently, there are 186.96M common shares owned by the public and among those 150.62M shares have been available to trade. The company’s stock has a 5-day price change of -24.32% and -21.95% over the past three months. TSHA shares are trading 26.55% year to date (YTD), with the 12-month market performance up to 279.66% higher. […]
Investors Should Take Note Of Taysha Gene Therapies Inc (TSHA)
Taysha Gene Therapies Inc (TSHA) concluded trading on Wednesday at a closing price of $2.04, with 10.12 million shares of worth about $20.64 million changed hands on the day. Half year performance of the stock remained positive as price took a surge of 25.15% during that period and on June 26, 2024 the price saw […]
Taysha Gene Therapies Inc (NASDAQ: TSHA) Loses -6.71% From High. Why That Could Change?
Currently, there are 186.96M common shares owned by the public and among those 139.88M shares have been available to trade. The company’s stock has a 5-day price change of 2.81% and 89.20% over the past three months. TSHA shares are trading 127.68% year to date (YTD), with the 12-month market performance up to 426.80% higher. […]
Taysha Gene Therapies Inc (NASDAQ: TSHA) – Not A Clear Buying Opportunity?
Taysha Gene Therapies Inc (TSHA) concluded trading on Wednesday at a closing price of $2.52, with 6.5 million shares of worth about $16.37 million changed hands on the day. Half year performance of the stock remained positive as price took a surge of 31.25% during that period and on Wednesday the price saw a gain […]
Is Taysha Gene Therapies Inc (NASDAQ: TSHA) Back In The Buying Zone?
Fidelity Management & Research Co recently announced the acquisition of new stake in Taysha Gene Therapies Inc (NASDAQ:TSHA). The institutional investor has increased its shareholding in the Healthcare company by 2,035.03% to 24.53 million shares with purchase of 23.38 million shares. This fresh investment now brings its stake to 13.12% valued currently at $43.17 million. […]
Some Investing Thoughts On Taysha Gene Therapies Inc (NASDAQ: TSHA)
Taysha Gene Therapies Inc (TSHA) concluded trading on December 20, 2023 at a closing price of $1.42, with 5.1 million shares of worth about $7.25 million changed hands on the day. Half year performance of the stock remained positive as price took a surge of 98.46% during that period and On Wednesday the price saw […]
Assessing Whether Taysha Gene Therapies Inc (NASDAQ: TSHA) Is Over- Or Undervalued
Fidelity Management & Research Co has recently announced that it has increased stake in Taysha Gene Therapies Inc (NASDAQ:TSHA) by 2,035.03%. After grabbing 24.53 million shares, the institutional investor is now in possession of 23.38 million shares of the Healthcare Company. The new investment brought the stake of investor firm to 13.12% having worth around […]
Taysha Gene Therapies Inc (NASDAQ: TSHA) Stock In Prove Me State
Fidelity Management & Research Co has recently announced that it has increased stake in Taysha Gene Therapies Inc (NASDAQ:TSHA) by 2,264.01%. After grabbing 27.16 million shares, the institutional investor is now in possession of 26.01 million shares of the Healthcare Company. The new investment brought the stake of investor firm to 14.53% having worth around […]
